298 results
A novel breakthrough in wrist-worn transdermal Troponin-I-Sensor assessment for acute myocardial infarction
23 Mar 2023
A transdermal-infrared spectrophotometric sensor (T-ISS) to assess troponins increase has been recently developed. This multicenter, observational study tested the feasibility of implementing this tool with machine learning analytics carried out in a cohort of patients presenting with acute coronary syndrome.
Reviewer
Reviewer
Essential drugs that every interventionalist needs to know
15 Dec 2022 – From GulfPCR-GIM 2022
In this GulfPCR-GIM 2022 session, learn about the role of PCSK9 inhibitors in ACS and post-PCI patients, the role of SGLT2 receptor blockers and GLP RAs, and the role of P2Y12 inhibitors as unique post-PCI antiplatelet agents.
Challenging ACS scenarios
14 Dec 2022 – From GulfPCR-GIM 2022
Topics in this GulfPCR-GIM 2022 session include the role of imaging in an unusual case of ACS in a young patient, PCI of an abnormal left coronary artery with AMI, embolisation of a thrombus in a non-culprit vessel during PCI in a late-presenting anterior STEMI, and...
First half of DK-Crush technique for bailout stenting of a true 0,0,1 bifurcation
09 Dec 2022
Stent implantation is largely debated in true 0,0,1 bifurcation lesion. This case shows bailout IVUS-guided stenting of a large diagonal branch after DEB-induced dissection, performed by employing the first half of the DK-Crush technique, thus avoiding stenting in the disease-free left anterior descending artery.
Author
Author
Author
2-year outcomes of angiographic quantitative flow ratio-guided coronary interventions
23 Nov 2022
FAVOR-III China was an investigator-initiated, multicentre, randomised, blinded, sham-controlled trial comparing clinical outcomes of QFR versus angiography-guided strategies for the treatment of non-critical lesions in patients with stable or unstable angina, or MI, at least 72 hours prior to screening. The one-year results showed improved clinical...
Reviewer
Aspirin vs Clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention: the HOST-EXAM extended study
08 Nov 2022
The HOST-EXAM trial1 was a prospective, randomised, open-label trial investigating clopidogrel monotherapy versus aspirin therapy in patients undergoing PCI with DES who had completed 6-18 months of DAPT with no ischaemic or bleeding complications. At 24 months follow-up, clopidogrel monotherapy significantly reduced the risk of the...
Reviewer
A patient with ACS – how should I treat the left main?
31 Oct 2022
Take a virtual trip to Chennai, India for this first PCR Webinar on the Road.
Optical coherence tomography fractional flow reserve and cardiovascular outcomes in patients with acute coronary syndrome
18 Oct 2022
Optical Coherence Tomography fractional flow reserve (OCT-FFR) has been shown to correlate well with wire-based FFR; however, clinical outcomes based on OCT-FFR are not well defined. In this retrospective study, the authors sought to investigate the relationship between OCT-FFR and long-term clinical outcomes in ACS.
Reviewer
Clinical cases - Coronary interventions - Session 4
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 5
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 8
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 1
06 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 3
06 Oct 2022 – From AICT-AsiaPCR 2022
BYPASS-CTCA: The value of computed tomography cardiac angiography in improving patient satisfaction and reducing contrast load, procedural duration and complications in patients who had previous CABG undergoing invasive coronary angiography
19 Sep 2022
Nicola Ryan provides her take on the BYPASS-CTCA Study which was presented by Daniel A. Jones at the TCT Congress 2022.
It must be understood that the paper has yet to be published for this study therefore all assumptions are based upon the presented data.
Author
Durable polymer vs. biodegradable polymer DES in patients with ACS undergoing complex PCI: A post hoc analysis of the HOST-REDUCE-POLYTECH-ACS trial
30 Aug 2022
The HOST-REDUCE-POLYTECH-ACS trial was a randomised, parallel-group multicentre trial with a 2x2 factorial design testing two independent hypotheses, one of which was the non-inferiority of durable polymer drug-eluting stents (DP-DES) to biodegradable polymer drug-eluting stents (BP-DES) in patients with ACS. In this post-hoc analysis, the authors...
Reviewer
Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study
25 Aug 2022
In this post-hoc analysis of the TWILIGHT trial, the authors report the effects of ticagrelor monotherapy compared to ticagrelor and aspirin in patients with prior CABG at least three months post PCI with no adverse events and at least one clinical and one angiographic high-risk feature...
Reviewer
How should I treat a patient at high-bleeding risk requiring complex distal Left Main PCI for ACS ?
17 Jun 2021
Discover the replay of this webinar on high bleeding risk and complex PCI, with E. Barbato, B. Chevalier, A. Chieffo and T. Cuisset
How to use invasive coronary physiology in ACS patients?
23 Sep 2021
Watch the replay of this webinar on coronary physiology with F. Alfonso, T. Engstrom, T. Keeble and R. Kharbanda
Timing and predictors of definite stent thrombosis in comatose survivors of out-of-hospital cardiac arrest undergoing percutaneous coronary intervention and therapeutic hypothermia (ST-OHCA study)
09 Aug 2022
The ST-OHCA study is a single centre prospective study investigating the incidence, timing and predictors of definite stent thrombosis in comatose survivors of out-of-hospital cardiac arrest (OHCA) undergoing immediate PCI and therapeutic hypothermia.
Reviewer
Radial versus femoral access in ACS patients undergoing complex PCI is associated with consistent bleeding benefit and no excess of risk
18 Jul 2022
In this paper, the authors investigated the comparative efficacy and safety of TRA versus TFA in ACS patients undergoing complex PCI in the Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX (MATRIX)-Access trial1.
Reviewer
Reviewer
